Legacy Pharmaceuticals

Activities: Manufacturing Pharmaceutical

Legacy Pharmaceuticals Switzerland is a Swiss contract manufacturer and service provider (Contract Manufacturing Organization) for the global pharmaceutical industry. Created in 2007 with the acquisition of certain products and our Basel manufacturing site, our roots go back to 1947, back to the years when the modern Swiss pharmaceutical industry was just getting started.

Trending Articles

  1. Beneo presents its taste-boosting excipient, galenIQ at CPHI 2024 galenIQ is designed to improve the flavour of oral solid dosage (OSD) forms for more patient-centric pharmaceuticals
  2. Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility The site will host biosafety testing, analytical development and cell banking manufacturing services
  3. Seppic launches surfactant excipient for the optimisation of biological formulations The ingredient is compatible with sensitive biologics, and aims to stabilise injectables for improved bioavailability, efficacy and shelf life
  4. Strides Group launches CDMO OneSource Specialty Pharma at CPHI Milan The newly integrated CDMO primarily specialises in the manufacture of biologics, drug-device combos and gelatin capsules
  5. Johnson & Johnson completes V-Wave acquisition to support patients with heart failure The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Media

COVID-19 and its effect on current and future pharmaceutical industry trends

As well as the ongoing efforts to find a treatment and a vaccine, COVID-19 will also drive the pharmaceutical industry to shorten its global supply chains through increased inventories and local manufacturing, says Michael Danzi, CEO, Legacy Pharmaceuticals
Manufacturing

Legacy Pharmaceuticals implements new customer service software in Switzerland

SAP S/4 HANA software has been implemented for all 250 employees
Manufacturing

Swiss CMO sets employee expansion goals

Legacy Pharmaceuticals has set a goal of 250 employees by year end in response to increasing demand for one-stop-shop drug products manufacturing services
Packaging

Legacy ramps up preparations for Russian track-and-trace regulations

Swiss pharma supplier has installed and certified new Bosch serialisation and aggregation equipment on three packaging lines
Containment

Legacy Pharmaceuticals announces long-term lyophilisation strategy

A lyophilisation suite is in the works, with closed RABS filling line technology, 2 to 3 freeze-driers up to 30 sqm each and automated load and unloading systems
Manufacturing

Legacy improves AntiViral drug with SCHOTT Type I plus vials

Legacy Pharmaceuticals and SCHOTT are now offering a solution to future customers with a need to provide better stability, particularly for highly sensitive formulations
Media

Developments and the future of pharmaceutical packaging

With the global primary packaging market in the pharmaceutical sector expected to experience remarkable growth during the next few years, Dr Kevin Robinson asked a number of industry experts to comment on the hurdles, drivers and emerging trends that are influencing how drugs are formulated, packaged and delivered
Subscribe now